Skip to main content
Intermediate Technical IVT

osteogenesis imperfecta

Pronunciation: OS-tee-oh-JEN-eh-sis im-per-FEK-tah

Genetic disorder affecting collagen production, resulting in brittle bones and increased fracture risk in children.

Full Definition

Osteogenesis imperfecta (OI) is a hereditary connective tissue disorder characterized by defective collagen synthesis, primarily affecting Type I collagen. Children with OI have bones that fracture easily, often with minimal trauma. The condition is classified into several types (I-VIII) with varying severity, from mild forms with normal stature to severe forms incompatible with life. Clinical features may include blue sclerae, hearing loss, dentinogenesis imperfecta, and short stature. Orthopedic management focuses on fracture prevention, treatment of deformities, and maximizing function and mobility.

Usage

Usage note: Often abbreviated as OI in clinical documentation. Always consider this diagnosis in children with recurrent fractures.

In Context

  • "The patient's history of multiple low-energy fractures and blue sclerae suggested a diagnosis of osteogenesis imperfecta." — genetic consultation report
  • "Bisphosphonate therapy has shown promise in reducing fracture rates in children with osteogenesis imperfecta." — treatment protocol document

Also known as

brittle bone disease

Contrasted with

normal bone density

Don't confuse with

osteopetrosis rickets child abuse

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON